智通财经APP获悉,据港交所10月31日消息,脑动极光医疗科技有限公司(简称:脑动极光)通过港交所主板上市聆讯,中金公司及浦银国际为其联席保荐人。招股书显示,脑动极光医疗成立于2012年,产品管线涵盖由血管疾病、神经退行性疾病、精神疾病及儿童发育缺陷等诱发的广泛的认知障碍的测评和干预。截至2024年10月22日,公司的核心产品脑功能信息管理平台软件系统已就四种主要类型认知障碍的八种适应症实现商业化...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.